A 21 Day Pharmacokinetics Study in Papulopustular Rosacea



Status:Not yet recruiting
Conditions:Cosmetic
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:18 - Any
Updated:5/3/2014
Start Date:January 2014

Use our guide to learn which trials are right for you!

A Phase 1, Open Label, Multiple Center Study to Evaluate the Pharmacokinetics of Once-Daily CLS001 Topical Gel Under Maximal Use Conditions Administered for 21 Days in Subjects With Papulopustular Rosacea

The purpose of this study is to characterize the pharmacokinetics of once daily topical gel
and confirm that steady state conditions are reached under maximal use conditions following
3 weeks of daily applications.


Inclusion Criteria:

- A diagnosis of papulopustular rosacea

- Grade 3 or 4 on the 5-point Investigator Global Assessment scale

- Presence of telangiectasia

Exclusion Criteria:

- steroid rosacea or subtype 3 (phymatous rosacea)

- clinically significant abnormal findings that would interfere with study objective or
risk to safety for the subject.

- nodular rosacea (lesions greater than 5mm with more than 2 modules)
We found this trial at
2
sites
Hackensack, New Jersey 07601
?
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Austin, Texas 78759
?
mi
from
Austin, TX
Click here to add this to my saved trials